Literature DB >> 21640424

Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: the Microalbuminuria Education and Medication Optimisation (MEMO) study.

W Crasto1, J Jarvis, K Khunti, T C Skinner, L J Gray, J Brela, J Troughton, H Daly, I G Lawrence, P G McNally, M E Carey, M J Davies.   

Abstract

AIMS: To determine whether tighter cardiovascular risk factor control with structured education in individuals with type 2 diabetes (T2DM) and microalbuminuria benefits cardiovascular risk factors.
METHODS: Participants from a multiethnic population, recruited from primary care and specialist clinics were randomised to intensive intervention with structured patient (DESMOND model) education (n=94) or usual care by own health professional (n=95). PRIMARY OUTCOME: change in HbA1c at 18months. SECONDARY OUTCOMES: changes in blood pressure (BP), cholesterol, albuminuria, proportion reaching risk factor targets, modelled cardiovascular risk scores.
RESULTS: Mean (SD) age and diabetes duration of participants were 61.5 (10.5) and 11.5 (9.3) years, respectively. At 18months, intensive intervention showed significant improvements in HbA1c (7.1(1.0) vs. 7.8(1.4)%, p<0.0001), systolic BP (129(16) vs. 139(17) mmHg, p<0.0001), diastolic BP (70(11) vs. 76(12) mmHg, p<0.001), total cholesterol (3.7(0.8) vs. 4.1(0.9) mmol/l, p=0.001). Moderate and severe hypoglycaemia was 11.2 vs. 29.0%; p=0.001 and 0 vs. 6.3%; p=0.07, respectively. More intensive participants achieved ≥3 risk factor targets with greater reductions in cardiovascular risk scores.
CONCLUSIONS: Intensive intervention showed greater improvements in metabolic control and cardiovascular risk profile with lower rates of moderate and severe hypoglycaemia. Intensive glycaemic interventions should be underpinned by structured education promoting self-management in T2DM.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640424     DOI: 10.1016/j.diabres.2011.05.008

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  12 in total

Review 1.  Hypoglycemia as an indicator of good diabetes care.

Authors:  Rene Rodriguez-Gutierrez; Kasia J Lipska; Rozalina G McCoy; Naykky Singh Ospina; Henry H Ting; Victor M Montori
Journal:  BMJ       Date:  2016-03-07

Review 2.  Glucose targets for preventing diabetic kidney disease and its progression.

Authors:  Marinella Ruospo; Valeria M Saglimbene; Suetonia C Palmer; Salvatore De Cosmo; Antonio Pacilli; Olga Lamacchia; Mauro Cignarelli; Paola Fioretto; Mariacristina Vecchio; Jonathan C Craig; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2017-06-08

Review 3.  Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis.

Authors:  Xiaoqin He; Jie Li; Bin Wang; Qiuming Yao; Ling Li; Ronghua Song; Xiaohong Shi; Jin-An Zhang
Journal:  Endocrine       Date:  2016-11-12       Impact factor: 3.633

Review 4.  Effectiveness and safety of patient activation interventions for adults with type 2 diabetes: systematic review, meta-analysis, and meta-regression.

Authors:  Shari D Bolen; Apoorva Chandar; Corinna Falck-Ytter; Carl Tyler; Adam T Perzynski; Alida M Gertz; Paulette Sage; Steven Lewis; Maurine Cobabe; Ying Ye; Michelle Menegay; Donna M Windish
Journal:  J Gen Intern Med       Date:  2014-04-15       Impact factor: 5.128

Review 5.  Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies.

Authors:  Chloe L Edridge; Alison J Dunkley; Danielle H Bodicoat; Tanith C Rose; Laura J Gray; Melanie J Davies; Kamlesh Khunti
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

6.  Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey.

Authors:  Lori Berard; Mireille Bonnemaire; Marie Mical; Steve Edelman
Journal:  Diabetes Obes Metab       Date:  2017-09-12       Impact factor: 6.577

7.  Hypoglycaemia in diabetes: do we think enough of the cause? An observational study on prevalence and causes of hypoglycaemia among patients with type 2 diabetes in an out-patient setting in Sri Lanka.

Authors:  H A Dissanayake; G S P Keerthisena; K K K Gamage; J H Liyanage; I R H S Ihalagama; W M U A Wijetunga; T A D Tillekaratne; G W Katulanda; P Katulanda
Journal:  BMC Endocr Disord       Date:  2018-06-08       Impact factor: 2.763

Review 8.  Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.

Authors:  Bo Ahrén
Journal:  Vasc Health Risk Manag       Date:  2013-04-24

Review 9.  Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Authors:  Clement Lo; Tadashi Toyama; Ying Wang; Jin Lin; Yoichiro Hirakawa; Min Jun; Alan Cass; Carmel M Hawley; Helen Pilmore; Sunil V Badve; Vlado Perkovic; Sophia Zoungas
Journal:  Cochrane Database Syst Rev       Date:  2018-09-24

Review 10.  Treat-to-target trials in diabetes.

Authors:  Subhash K Wangnoo; Bipin Sethi; Rakesh K Sahay; Mathew John; Samit Ghosal; Surendra K Sharma
Journal:  Indian J Endocrinol Metab       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.